Selected article for: "endothelial growth factor and VEGF endothelial growth factor"
Author: Zhu, Zhen-Hong; Song, Wen-Qi; Zhang, Chang-Qing; Yin, Ji-Min
Title: Dimethyloxaloylglycine increases bone repair capacity of adipose-derived stem cells in the treatment of osteonecrosis of the femoral head
  • Document date: 2016_9_13
    • ID: kjvy2c2k_2
    Snippet: Previous studies have described the use of mesenchymal stem cells (MSCs) to promote local bone repair and healing (5, 6) . MSCs are pluripotent and can differentiate into several lineages of cells, which have shown potency in the treatment of numerous ischemic diseases, such as myocardial infarction (7, 8) , nerve injury (9) and bone defect (10) . Prior studies have found that the implantation of MSCs into the necrotic area of the femoral head wa.....
    Document: Previous studies have described the use of mesenchymal stem cells (MSCs) to promote local bone repair and healing (5, 6) . MSCs are pluripotent and can differentiate into several lineages of cells, which have shown potency in the treatment of numerous ischemic diseases, such as myocardial infarction (7, 8) , nerve injury (9) and bone defect (10) . Prior studies have found that the implantation of MSCs into the necrotic area of the femoral head was able to improve local bone regeneration (11, 12) . MSCs are able to differentiate into osteoblasts to promote local bone healing directly (13, 14) . Furthermore, MSCs are able to secrete growth factors such as vascular endothelial growth factor (VEGF), angiopoietin 1, stromal cell-derived factor 1 and basic fibroblast growth factor, which have angiogenic potency and can promote local revascularization, thereby improving bone healing indirectly (15, 16) .

    Search related documents:
    Co phrase search for related documents
    • fibroblast growth factor and ischemic disease: 1
    • fibroblast growth factor and mesenchymal stem cell: 1
    • fibroblast growth factor and myocardial infarction: 1, 2
    • fibroblast growth factor and nerve injury: 1
    • fibroblast growth factor and previous study: 1, 2
    • fibroblast growth factor and stem cell: 1, 2, 3, 4
    • fibroblast growth factor and vascular VEGF endothelial growth factor: 1, 2, 3, 4, 5
    • fibroblast growth factor and VEGF endothelial growth factor: 1, 2, 3, 4, 5
    • growth factor and ischemic disease: 1, 2, 3, 4
    • growth factor and mesenchymal stem cell: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • growth factor and msc mesenchymal stem cell: 1, 2, 3, 4, 5
    • growth factor and myocardial infarction: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • growth factor and nerve injury: 1, 2
    • previous study and prior study: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
    • previous study and stem cell: 1, 2
    • prior study and stem cell: 1, 2, 3
    • stem cell and vascular VEGF endothelial growth factor: 1, 2, 3
    • stem cell and VEGF endothelial growth factor: 1, 2, 3
    • vascular VEGF endothelial growth factor and VEGF endothelial growth factor: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73